Sanofi News — every source, one live feed
Track Sanofi news in real time — French pharmaceutical company built around Dupixent, vaccines, and rare disease treatments.. fllwup^ collects the latest Sanofi headlines from every major source into one live feed — free, no account, no algorithm. Coverage aggregated from BBC, Reuters, AP, NYT, TechCrunch, Al Jazeera, and 200+ other outlets.
Latest Sanofi headlines
- Sanofi Weighs Takeover of US Drugmaker Insmed — Bloomberg.com
- As Sanofi's Pompe drug shortage drags on, some patients struggle to access treatments — CNBC
- Sanofi's pill becomes first US-approved drug for rare neurological disorder — Reuters
- Sanofi and Regeneron’s rare disease wins; Lilly’s dealmaking dance — Yahoo Finance
- FDA Approval for Sanofi Drug Marks an Important First in Rare Disease — MedCity News
- Sanofi gains FDA clearance for Gaucher disease pill — BioPharma Dive
- Sanofi and Regeneron’s rare disease wins; Lilly’s dealmaking dance — Pharma Voice
- Insmed shares jump more than 18% on report Sanofi is weighing acquisition — Investing.com
- FDA approves Sanofi pill as first treatment for brain effects of rare Gaucher disease — MedWatch
- Pharmalittle: We're reading about a Merck AI deal, China and the pharma supply chain, and more — STAT
Follow Sanofi live on fllwup^ · Follow in any RSS reader — or browse all topics.
More Global Stocks & ADRs: browse the category. Compare: fllwup^ vs Flipboard · vs Feedly · vs Google News · vs Apple News.